Heron Therapeutics
HRTX
#8207
Rank
โ‚น22.31 B
Marketcap
โ‚น121.69
Share price
3.05%
Change (1 day)
-17.87%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น21.09 Billion

According to Heron Therapeutics's latest financial reports the company's total liabilities are โ‚น21.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น22.88 B7.19%
2023-12-31โ‚น21.35 B8.7%
2022-12-31โ‚น19.64 B15.68%
2021-12-31โ‚น16.98 B98.34%
2020-12-31โ‚น8.56 B10.2%
2019-12-31โ‚น7.76 B20.75%
2018-12-31โ‚น6.43 B-2.33%
2017-12-31โ‚น6.58 B9.25%
2016-12-31โ‚น6.02 B359.77%
2015-12-31โ‚น1.31 B51.93%
2014-12-31โ‚น0.86 B99.83%
2013-12-31โ‚น0.43 B89.92%
2012-12-31โ‚น0.22 B16.42%
2011-12-31โ‚น0.19 B173.34%
2010-12-31โ‚น71.47 M-28.52%
2009-12-31โ‚น99.99 M-50.49%
2008-12-31โ‚น0.20 B-31.16%
2007-12-31โ‚น0.29 B27.59%
2006-12-31โ‚น0.22 B84.75%
2005-12-31โ‚น0.12 B0.49%
2004-12-31โ‚น0.12 B43.79%
2003-12-31โ‚น86.14 M-22.64%
2002-12-31โ‚น0.11 B-46.77%
2001-12-31โ‚น0.20 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alkermes
ALKS
โ‚น53.73 B 154.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
โ‚น51.41 B 143.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น19.49 B-7.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น47.46 B 124.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
โ‚น5.27 B-75.00%๐Ÿ‡บ๐Ÿ‡ธ USA